Concepedia

Adele Noè

AN

Statistics

Publications

14

Citations

1.3K

H-Index

13

Active since

1984

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

Ospedale Papa Giovanni XXIII

Hospital Universitario Virgen de la Arrixaca

University Hospital Leipzig

Adele Noè is an author at Novartis (Switzerland) specializing in medicine, pharmacotherapy, and cardiovascular disease.

Top concepts

Publications per year

1984–2020

14

Publications

14

Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual‐Acting Angiotensin Receptor—Neprilysin Inhibitor (ARNi)

Jessie Gu, Adele Noè, Priya Chandra et al. · The Journal of Clinical Pharmacology · 2009 · 494 citations

, , +11

Initiation of Sacubitril/Valsartan in Haemodynamically Stabilised Heart Failure Patients in Hospital or Early After Discharge: Primary Results of the Randomised TRANSITION Study

Rolf Wachter, Michele Senni, Jan Bělohlávek et al. · European Journal of Heart Failure · 2019 · 347 citations · Full text

International REgistry to Assess Medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): Rationale for and Design of a Global Registry

Gerasimos Filippatos, Sadiya S. Khan, Andrew P. Ambrosy et al. · European Journal of Heart Failure · 2015 · 67 citations · Full text

Initiation of Sacubitril/Valsartan Shortly After Hospitalisation for Acutely Decompensated Heart Failure in Patients with Newly Diagnosed ( <i>de novo</i> ) Heart Failure: A Subgroup Analysis of the TRANSITION Study

Michele Senni, Rolf Wachter, Klaus K. Witte et al. · European Journal of Heart Failure · 2019 · 64 citations · Full text

Rationale and Design of TRANSITION: A Randomized Trial of Pre-Discharge vs. Post-Discharge Initiation of Sacubitril/Valsartan

Domingo A. Pascual‐Figal, Rolf Wachter, Michele Senni et al. · ESC Heart Failure · 2017 · 59 citations · Full text

1–5 of 14